Fresh analysis reveals that individuals who discontinue popular GLP-1 drugs like semaglutide or tirzepatide may regain lost weight far faster than those who stop conventional diet and exercise programs.
Published data in a leading health publication shows that while obese individuals frequently drop substantial amounts of their total mass while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals purchasing these treatments should be informed of the danger of fast weight regain when the treatment ends," stated researcher Dr. Susan Jebb.
That rate of recovery implies a reversion to starting weight in about 18 months.
Comparing Approaches
The analysis, which looked at dozens of trials involving thousands of participants, contrasted the effects of GLP-1 agonists with other pills.
The team point out that individuals who lose weight through diet and exercise typically have a slower creep back—around 0.1 kg a month—once they finish.
Explaining the Quick Regain
Doctors suggest the mode of action of the drugs is key to understanding the amplified regain.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication results in appetite is no longer kept in check, making overeating far more likely."
A Lifelong Issue?
Medical guidelines recommend the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Professionals argue that, given the significant potential of weight regain, the therapy is often ongoing.
This view is echoed by pharmaceutical companies, who note that the findings "underscore the long-term character of excess weight," similar to managing diseases like high blood pressure.
Patient Testimonies
Users who have come off the jabs report a intense resurgence of appetite.
"It was like something that goes on and you're instantly starving," described a patient.
This difficulty is exacerbated if users have not adopted sustainable dietary or behavioural modifications during treatment.
Significant Interest
Recent estimates suggest that millions of people in the UK have used weight-loss jabs in the past year, with demand being substantial.
- Use is higher among women compared to males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, clinicians emphasize that while the jabs are powerful agents for weight loss, they are not a magic fix and maintained weight loss hinges on ongoing lifestyle changes.
